Nucleic acids research

The advanced systems developed at ChemBioPharm are based on hybrid bioinspired molecules involving different innovative combinations of biomolecular synthetic units with nucleic acids moieties. ChemBioPharm is working on four key research areas.

Drug delivery

Engineering supramolecular and nano materials for drug delivery applications

Regenerative medicine

Using non-polymeric scaffolds based on supramolecular matrix for regenerative medicine

Medicinal chemistry

Engineering oligonucleotides to reach specific drug targets

Biomaterials

Engineering supramolecular materials derived from nucleic acid chemistry

Partnership

The Chembiopharm team values scientific exchanges by being part of different research organisations. 

The main partnerships of chembiopharm are :

GDR RNA

GIS Frenchbic

FR Ki-NOA.